New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed ...

ATH-1105 is the Company's novel, orally available, brain-penetrant, next-generation small molecule drug candidate designed to ...

Significant adverse events — such as ARIA — with lecanemab, the drug that slows Alzheimer's, is rare and manageable, ...

Close collaboration between researchers and clinicians at Mayo is what makes the steps of translation — from discovery to the ...

The real-world data showed lower rates of atrial fibrillation and hypertension associated with the second-generation Bruton ...

A French government working group recommended a sweeping plan to publicize study data and issue guidelines for reporting ...

Randomised controlled trials are the gold standard to assess the effectiveness and safety of clinical interventions; however, ...

Omeros Corporation (NASDAQ: OMER) Q1 2025 Earnings Call Transcript May 15, 2025 Omeros Corporation misses on earnings ...

Careful examination of clinical trial data and a better understanding of risk factors can help rheumatologists determine if a ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. plans to require all new vaccines be tested against a placebo ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Operator: Greetings and welcome to the BiomX First Quarter 2025 Financial Results Conference Call. At this time, all ...